Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China Article Swipe
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1097/md.0000000000036798
To confirm whether ocular symptoms and complaints related to the COVID-19 infection persist after recovery. A cross-sectional study was conducted on people who came to the healthcare center for regular physical examinations when the lockdown lifted for nearly 1 month. Ophthalmologists performed comprehensive ocular examinations. The infection history of COVID-19 was identified by a self-reported reverse transcription-PCR (RT-PCR) test of a nasopharyngeal swab sample for SARS-CoV-2 or a novel coronavirus antigen test with self-reported typical infection symptoms. Demographic data was collected from their healthcare reports. Ocular history and ocular symptoms were collected through face-to-face interviewing. Of a total of 308 participants, 264 (85.7%) reported COVID-19 infection; 73 (27.65%) of infected persons complained of various ocular symptoms during or after infection; and only 15 (5.68%) persons reported ocular symptoms after recovery. Infection significantly increased the complaints of red eye and eye pain compared to the time before knockdown. There were no significant differences between infections and noninfectious infections in various ocular examinations at the time of examination. The duration between the day of infection onset and examination day was unrelated to all ocular examinations. COVID-19 infection can lead to some ocular symptoms, especially conjunctival congestion and ocular pain in the infective stage, but may not cause persistent ocular symptoms in about 1 month after recovery. The results of this study may help relieve public concerns about coronavirus infection in the eyes. However, more studies on various coronavirus infections, with large sample sizes, are warranted in multi-center and community-based populations.
Related Topics
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1097/md.0000000000036798
- OA Status
- gold
- Cited By
- 1
- References
- 39
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4390099234
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4390099234Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1097/md.0000000000036798Digital Object Identifier
- Title
-
Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, ChinaWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-12-22Full publication date if available
- Authors
-
Ruili Li, Jing Zhang, Yong Zhang, Lin‐Fa Wang, Xiaoya Qi, Yao ChenList of authors in order
- Landing page
-
https://doi.org/10.1097/md.0000000000036798Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1097/md.0000000000036798Direct OA link when available
- Concepts
-
Medicine, Cross-sectional study, Coronavirus disease 2019 (COVID-19), Pandemic, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Pediatrics, Internal medicine, Disease, Infectious disease (medical specialty), PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
39Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4390099234 |
|---|---|
| doi | https://doi.org/10.1097/md.0000000000036798 |
| ids.doi | https://doi.org/10.1097/md.0000000000036798 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/38134065 |
| ids.openalex | https://openalex.org/W4390099234 |
| fwci | 0.44923236 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000175 |
| mesh[1].descriptor_ui | D000086382 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | diagnosis |
| mesh[1].descriptor_name | COVID-19 |
| mesh[2].qualifier_ui | Q000453 |
| mesh[2].descriptor_ui | D000086382 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | epidemiology |
| mesh[2].descriptor_name | COVID-19 |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000086402 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | SARS-CoV-2 |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D003430 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Cross-Sectional Studies |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D003140 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Communicable Disease Control |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D014786 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Vision Disorders |
| mesh[7].qualifier_ui | Q000453 |
| mesh[7].descriptor_ui | D002681 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | epidemiology |
| mesh[7].descriptor_name | China |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D058447 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Eye Pain |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D006801 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Humans |
| mesh[10].qualifier_ui | Q000175 |
| mesh[10].descriptor_ui | D000086382 |
| mesh[10].is_major_topic | True |
| mesh[10].qualifier_name | diagnosis |
| mesh[10].descriptor_name | COVID-19 |
| mesh[11].qualifier_ui | Q000453 |
| mesh[11].descriptor_ui | D000086382 |
| mesh[11].is_major_topic | True |
| mesh[11].qualifier_name | epidemiology |
| mesh[11].descriptor_name | COVID-19 |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D000086402 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | SARS-CoV-2 |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D003430 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Cross-Sectional Studies |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D003140 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Communicable Disease Control |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D014786 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Vision Disorders |
| mesh[16].qualifier_ui | Q000453 |
| mesh[16].descriptor_ui | D002681 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | epidemiology |
| mesh[16].descriptor_name | China |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D058447 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Eye Pain |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D006801 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Humans |
| mesh[19].qualifier_ui | Q000175 |
| mesh[19].descriptor_ui | D000086382 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | diagnosis |
| mesh[19].descriptor_name | COVID-19 |
| mesh[20].qualifier_ui | Q000453 |
| mesh[20].descriptor_ui | D000086382 |
| mesh[20].is_major_topic | True |
| mesh[20].qualifier_name | epidemiology |
| mesh[20].descriptor_name | COVID-19 |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D000086402 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | SARS-CoV-2 |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D003430 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Cross-Sectional Studies |
| mesh[23].qualifier_ui | |
| mesh[23].descriptor_ui | D003140 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | |
| mesh[23].descriptor_name | Communicable Disease Control |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D014786 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Vision Disorders |
| mesh[25].qualifier_ui | Q000453 |
| mesh[25].descriptor_ui | D002681 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | epidemiology |
| mesh[25].descriptor_name | China |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D058447 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Eye Pain |
| type | article |
| title | Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China |
| biblio.issue | 51 |
| biblio.volume | 102 |
| biblio.last_page | e36798 |
| biblio.first_page | e36798 |
| topics[0].id | https://openalex.org/T12599 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2731 |
| topics[0].subfield.display_name | Ophthalmology |
| topics[0].display_name | Retinal and Optic Conditions |
| topics[1].id | https://openalex.org/T11368 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9934999942779541 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2728 |
| topics[1].subfield.display_name | Neurology |
| topics[1].display_name | Long-Term Effects of COVID-19 |
| topics[2].id | https://openalex.org/T11929 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9853000044822693 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2728 |
| topics[2].subfield.display_name | Neurology |
| topics[2].display_name | Cerebral Venous Sinus Thrombosis |
| is_xpac | False |
| apc_list.value | 1950 |
| apc_list.currency | USD |
| apc_list.value_usd | 1950 |
| apc_paid.value | 1950 |
| apc_paid.currency | USD |
| apc_paid.value_usd | 1950 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9335082769393921 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C142052008 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7455917596817017 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q954027 |
| concepts[1].display_name | Cross-sectional study |
| concepts[2].id | https://openalex.org/C3008058167 |
| concepts[2].level | 4 |
| concepts[2].score | 0.43849119544029236 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q84263196 |
| concepts[2].display_name | Coronavirus disease 2019 (COVID-19) |
| concepts[3].id | https://openalex.org/C89623803 |
| concepts[3].level | 5 |
| concepts[3].score | 0.4324849247932434 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12184 |
| concepts[3].display_name | Pandemic |
| concepts[4].id | https://openalex.org/C3007834351 |
| concepts[4].level | 5 |
| concepts[4].score | 0.42254817485809326 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q82069695 |
| concepts[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| concepts[5].id | https://openalex.org/C187212893 |
| concepts[5].level | 1 |
| concepts[5].score | 0.3513297736644745 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[5].display_name | Pediatrics |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.30514684319496155 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C2779134260 |
| concepts[7].level | 2 |
| concepts[7].score | 0.2225298285484314 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[7].display_name | Disease |
| concepts[8].id | https://openalex.org/C524204448 |
| concepts[8].level | 3 |
| concepts[8].score | 0.12418374419212341 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q788926 |
| concepts[8].display_name | Infectious disease (medical specialty) |
| concepts[9].id | https://openalex.org/C142724271 |
| concepts[9].level | 1 |
| concepts[9].score | 0.12342339754104614 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[9].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9335082769393921 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/cross-sectional-study |
| keywords[1].score | 0.7455917596817017 |
| keywords[1].display_name | Cross-sectional study |
| keywords[2].id | https://openalex.org/keywords/coronavirus-disease-2019 |
| keywords[2].score | 0.43849119544029236 |
| keywords[2].display_name | Coronavirus disease 2019 (COVID-19) |
| keywords[3].id | https://openalex.org/keywords/pandemic |
| keywords[3].score | 0.4324849247932434 |
| keywords[3].display_name | Pandemic |
| keywords[4].id | https://openalex.org/keywords/severe-acute-respiratory-syndrome-coronavirus-2 |
| keywords[4].score | 0.42254817485809326 |
| keywords[4].display_name | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
| keywords[5].id | https://openalex.org/keywords/pediatrics |
| keywords[5].score | 0.3513297736644745 |
| keywords[5].display_name | Pediatrics |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.30514684319496155 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/disease |
| keywords[7].score | 0.2225298285484314 |
| keywords[7].display_name | Disease |
| keywords[8].id | https://openalex.org/keywords/infectious-disease |
| keywords[8].score | 0.12418374419212341 |
| keywords[8].display_name | Infectious disease (medical specialty) |
| keywords[9].id | https://openalex.org/keywords/pathology |
| keywords[9].score | 0.12342339754104614 |
| keywords[9].display_name | Pathology |
| language | en |
| locations[0].id | doi:10.1097/md.0000000000036798 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S28966261 |
| locations[0].source.issn | 0025-7974, 1536-5964 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0025-7974 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Medicine |
| locations[0].source.host_organization | https://openalex.org/P4310318547 |
| locations[0].source.host_organization_name | Wolters Kluwer |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310318547 |
| locations[0].license | cc-by-nc |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Medicine |
| locations[0].landing_page_url | https://doi.org/10.1097/md.0000000000036798 |
| locations[1].id | pmid:38134065 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Medicine |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/38134065 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:10735152 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | cc-by-nc |
| locations[2].pdf_url | https://pmc.ncbi.nlm.nih.gov/articles/PMC10735152/pdf/medi-102-e36798.pdf |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | https://openalex.org/licenses/cc-by-nc |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Medicine (Baltimore) |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/10735152 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5101419249 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ruili Li |
| authorships[0].countries | US |
| authorships[0].affiliations[0].raw_affiliation_string | How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I285663978 |
| authorships[0].affiliations[1].raw_affiliation_string | 102:51(e36798). |
| authorships[0].institutions[0].id | https://openalex.org/I285663978 |
| authorships[0].institutions[0].ror | https://ror.org/02xwsbr93 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I285663978 |
| authorships[0].institutions[0].country_code | US |
| authorships[0].institutions[0].display_name | Weatherford College |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ruili Li |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | 102:51(e36798)., How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[1].author.id | https://openalex.org/A5114117954 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-0810-3827 |
| authorships[1].author.display_name | Jing Zhang |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I285663978 |
| authorships[1].affiliations[0].raw_affiliation_string | 102:51(e36798). |
| authorships[1].affiliations[1].raw_affiliation_string | How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[1].institutions[0].id | https://openalex.org/I285663978 |
| authorships[1].institutions[0].ror | https://ror.org/02xwsbr93 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I285663978 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Weatherford College |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Jing Zhang |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | 102:51(e36798)., How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[2].author.id | https://openalex.org/A5100619206 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-1436-5951 |
| authorships[2].author.display_name | Yong Zhang |
| authorships[2].countries | CN, US |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I285663978 |
| authorships[2].affiliations[0].raw_affiliation_string | 102:51(e36798). |
| authorships[2].affiliations[1].raw_affiliation_string | How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[2].affiliations[2].institution_ids | https://openalex.org/I4210153612, https://openalex.org/I87780372 |
| authorships[2].affiliations[2].raw_affiliation_string | School of Public Health, Chongqing Medical University, Chongqing, China. |
| authorships[2].institutions[0].id | https://openalex.org/I87780372 |
| authorships[2].institutions[0].ror | https://ror.org/017z00e58 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I87780372 |
| authorships[2].institutions[0].country_code | CN |
| authorships[2].institutions[0].display_name | Chongqing Medical University |
| authorships[2].institutions[1].id | https://openalex.org/I4210153612 |
| authorships[2].institutions[1].ror | https://ror.org/04dcmpg83 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I4210153612 |
| authorships[2].institutions[1].country_code | CN |
| authorships[2].institutions[1].display_name | Chongqing Public Health Medical Center |
| authorships[2].institutions[2].id | https://openalex.org/I285663978 |
| authorships[2].institutions[2].ror | https://ror.org/02xwsbr93 |
| authorships[2].institutions[2].type | education |
| authorships[2].institutions[2].lineage | https://openalex.org/I285663978 |
| authorships[2].institutions[2].country_code | US |
| authorships[2].institutions[2].display_name | Weatherford College |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Yong Zhang |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | 102:51(e36798)., How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023, School of Public Health, Chongqing Medical University, Chongqing, China. |
| authorships[3].author.id | https://openalex.org/A5049518482 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-2752-0535 |
| authorships[3].author.display_name | Lin‐Fa Wang |
| authorships[3].countries | US |
| authorships[3].affiliations[0].raw_affiliation_string | How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I285663978 |
| authorships[3].affiliations[1].raw_affiliation_string | 102:51(e36798). |
| authorships[3].institutions[0].id | https://openalex.org/I285663978 |
| authorships[3].institutions[0].ror | https://ror.org/02xwsbr93 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I285663978 |
| authorships[3].institutions[0].country_code | US |
| authorships[3].institutions[0].display_name | Weatherford College |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Lihua Wang |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | 102:51(e36798)., How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[4].author.id | https://openalex.org/A5057986676 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-0998-1883 |
| authorships[4].author.display_name | Xiaoya Qi |
| authorships[4].countries | US |
| authorships[4].affiliations[0].raw_affiliation_string | How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I285663978 |
| authorships[4].affiliations[1].raw_affiliation_string | 102:51(e36798). |
| authorships[4].institutions[0].id | https://openalex.org/I285663978 |
| authorships[4].institutions[0].ror | https://ror.org/02xwsbr93 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I285663978 |
| authorships[4].institutions[0].country_code | US |
| authorships[4].institutions[0].display_name | Weatherford College |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Xiaoya Qi |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | 102:51(e36798)., How to cite this article: Li R, Zhang J, Zhang Y, Wang L, Qi X, Chen Y. Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China. Medicine 2023 |
| authorships[5].author.id | https://openalex.org/A5100394234 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-7120-0902 |
| authorships[5].author.display_name | Yao Chen |
| authorships[5].countries | CN |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I191996457, https://openalex.org/I4210097509, https://openalex.org/I87780372 |
| authorships[5].affiliations[0].raw_affiliation_string | Yao Chen, Department of Health Medicine Center, The Second Hospital Affiliated to Chongqing Medical University, Chongqing, 400013, China (e-mail |
| authorships[5].institutions[0].id | https://openalex.org/I87780372 |
| authorships[5].institutions[0].ror | https://ror.org/017z00e58 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I87780372 |
| authorships[5].institutions[0].country_code | CN |
| authorships[5].institutions[0].display_name | Chongqing Medical University |
| authorships[5].institutions[1].id | https://openalex.org/I191996457 |
| authorships[5].institutions[1].ror | https://ror.org/04c8eg608 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I191996457 |
| authorships[5].institutions[1].country_code | CN |
| authorships[5].institutions[1].display_name | Dalian Medical University |
| authorships[5].institutions[2].id | https://openalex.org/I4210097509 |
| authorships[5].institutions[2].ror | https://ror.org/00r67fz39 |
| authorships[5].institutions[2].type | healthcare |
| authorships[5].institutions[2].lineage | https://openalex.org/I4210097509 |
| authorships[5].institutions[2].country_code | CN |
| authorships[5].institutions[2].display_name | Second Affiliated Hospital of Chongqing Medical University |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Yao Chen |
| authorships[5].is_corresponding | True |
| authorships[5].raw_affiliation_strings | Yao Chen, Department of Health Medicine Center, The Second Hospital Affiliated to Chongqing Medical University, Chongqing, 400013, China (e-mail |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1097/md.0000000000036798 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Does SARS-CoV-2 infection cause persistent ocular symptoms?: A cross-sectional study after the lifting of lockdown in Chongqing, China |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12599 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2731 |
| primary_topic.subfield.display_name | Ophthalmology |
| primary_topic.display_name | Retinal and Optic Conditions |
| related_works | https://openalex.org/W4206669628, https://openalex.org/W4205317059, https://openalex.org/W3081785542, https://openalex.org/W3119540162, https://openalex.org/W3176864053, https://openalex.org/W3198183218, https://openalex.org/W4205810683, https://openalex.org/W4224279380, https://openalex.org/W4206548596, https://openalex.org/W4206651655 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1097/md.0000000000036798 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S28966261 |
| best_oa_location.source.issn | 0025-7974, 1536-5964 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0025-7974 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Medicine |
| best_oa_location.source.host_organization | https://openalex.org/P4310318547 |
| best_oa_location.source.host_organization_name | Wolters Kluwer |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| best_oa_location.license | cc-by-nc |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by-nc |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Medicine |
| best_oa_location.landing_page_url | https://doi.org/10.1097/md.0000000000036798 |
| primary_location.id | doi:10.1097/md.0000000000036798 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S28966261 |
| primary_location.source.issn | 0025-7974, 1536-5964 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0025-7974 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Medicine |
| primary_location.source.host_organization | https://openalex.org/P4310318547 |
| primary_location.source.host_organization_name | Wolters Kluwer |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310318547 |
| primary_location.license | cc-by-nc |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by-nc |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Medicine |
| primary_location.landing_page_url | https://doi.org/10.1097/md.0000000000036798 |
| publication_date | 2023-12-22 |
| publication_year | 2023 |
| referenced_works | https://openalex.org/W3136955306, https://openalex.org/W3206065137, https://openalex.org/W6791513857, https://openalex.org/W4283379109, https://openalex.org/W4220920719, https://openalex.org/W3024818240, https://openalex.org/W3020134225, https://openalex.org/W3013353381, https://openalex.org/W3082586092, https://openalex.org/W3036468419, https://openalex.org/W3054946272, https://openalex.org/W4312093668, https://openalex.org/W3081565716, https://openalex.org/W3080221360, https://openalex.org/W3033992719, https://openalex.org/W6800369320, https://openalex.org/W3047786212, https://openalex.org/W3085528345, https://openalex.org/W3045084279, https://openalex.org/W3045180535, https://openalex.org/W3033243614, https://openalex.org/W3034613649, https://openalex.org/W4210242202, https://openalex.org/W3081503730, https://openalex.org/W3202741754, https://openalex.org/W3095650061, https://openalex.org/W6807238786, https://openalex.org/W3123006259, https://openalex.org/W3107532169, https://openalex.org/W6775869999, https://openalex.org/W3159531094, https://openalex.org/W3034142655, https://openalex.org/W4206705051, https://openalex.org/W3158836917, https://openalex.org/W3165461144, https://openalex.org/W4293216410, https://openalex.org/W3004318991, https://openalex.org/W3096975136, https://openalex.org/W6796485361 |
| referenced_works_count | 39 |
| abstract_inverted_index.1 | 38, 210 |
| abstract_inverted_index.A | 15 |
| abstract_inverted_index.a | 53, 60, 67, 96 |
| abstract_inverted_index.15 | 122 |
| abstract_inverted_index.73 | 106 |
| abstract_inverted_index.Of | 95 |
| abstract_inverted_index.To | 0 |
| abstract_inverted_index.at | 161 |
| abstract_inverted_index.by | 52 |
| abstract_inverted_index.in | 157, 197, 208, 227, 243 |
| abstract_inverted_index.no | 149 |
| abstract_inverted_index.of | 48, 59, 98, 108, 112, 135, 164, 171, 216 |
| abstract_inverted_index.on | 20, 233 |
| abstract_inverted_index.or | 66, 117 |
| abstract_inverted_index.to | 8, 24, 142, 179, 187 |
| abstract_inverted_index.264 | 101 |
| abstract_inverted_index.308 | 99 |
| abstract_inverted_index.The | 45, 166, 214 |
| abstract_inverted_index.all | 180 |
| abstract_inverted_index.and | 5, 87, 120, 138, 154, 174, 194, 245 |
| abstract_inverted_index.are | 241 |
| abstract_inverted_index.but | 201 |
| abstract_inverted_index.can | 185 |
| abstract_inverted_index.day | 170, 176 |
| abstract_inverted_index.eye | 137, 139 |
| abstract_inverted_index.for | 28, 36, 64 |
| abstract_inverted_index.may | 202, 219 |
| abstract_inverted_index.not | 203 |
| abstract_inverted_index.red | 136 |
| abstract_inverted_index.the | 9, 25, 33, 133, 143, 162, 169, 198, 228 |
| abstract_inverted_index.was | 18, 50, 79, 177 |
| abstract_inverted_index.who | 22 |
| abstract_inverted_index.came | 23 |
| abstract_inverted_index.data | 78 |
| abstract_inverted_index.from | 81 |
| abstract_inverted_index.help | 220 |
| abstract_inverted_index.lead | 186 |
| abstract_inverted_index.more | 231 |
| abstract_inverted_index.only | 121 |
| abstract_inverted_index.pain | 140, 196 |
| abstract_inverted_index.some | 188 |
| abstract_inverted_index.swab | 62 |
| abstract_inverted_index.test | 58, 71 |
| abstract_inverted_index.this | 217 |
| abstract_inverted_index.time | 144, 163 |
| abstract_inverted_index.were | 90, 148 |
| abstract_inverted_index.when | 32 |
| abstract_inverted_index.with | 72, 237 |
| abstract_inverted_index.There | 147 |
| abstract_inverted_index.about | 209, 224 |
| abstract_inverted_index.after | 13, 118, 128, 212 |
| abstract_inverted_index.cause | 204 |
| abstract_inverted_index.eyes. | 229 |
| abstract_inverted_index.large | 238 |
| abstract_inverted_index.month | 211 |
| abstract_inverted_index.novel | 68 |
| abstract_inverted_index.onset | 173 |
| abstract_inverted_index.study | 17, 218 |
| abstract_inverted_index.their | 82 |
| abstract_inverted_index.total | 97 |
| abstract_inverted_index.Ocular | 85 |
| abstract_inverted_index.before | 145 |
| abstract_inverted_index.center | 27 |
| abstract_inverted_index.during | 116 |
| abstract_inverted_index.lifted | 35 |
| abstract_inverted_index.month. | 39 |
| abstract_inverted_index.nearly | 37 |
| abstract_inverted_index.ocular | 3, 43, 88, 114, 126, 159, 181, 189, 195, 206 |
| abstract_inverted_index.people | 21 |
| abstract_inverted_index.public | 222 |
| abstract_inverted_index.sample | 63, 239 |
| abstract_inverted_index.sizes, | 240 |
| abstract_inverted_index.stage, | 200 |
| abstract_inverted_index.(5.68%) | 123 |
| abstract_inverted_index.(85.7%) | 102 |
| abstract_inverted_index.antigen | 70 |
| abstract_inverted_index.between | 152, 168 |
| abstract_inverted_index.confirm | 1 |
| abstract_inverted_index.history | 47, 86 |
| abstract_inverted_index.persist | 12 |
| abstract_inverted_index.persons | 110, 124 |
| abstract_inverted_index.regular | 29 |
| abstract_inverted_index.related | 7 |
| abstract_inverted_index.relieve | 221 |
| abstract_inverted_index.results | 215 |
| abstract_inverted_index.reverse | 55 |
| abstract_inverted_index.studies | 232 |
| abstract_inverted_index.through | 92 |
| abstract_inverted_index.typical | 74 |
| abstract_inverted_index.various | 113, 158, 234 |
| abstract_inverted_index.whether | 2 |
| abstract_inverted_index.(27.65%) | 107 |
| abstract_inverted_index.(RT-PCR) | 57 |
| abstract_inverted_index.COVID-19 | 10, 49, 104, 183 |
| abstract_inverted_index.However, | 230 |
| abstract_inverted_index.compared | 141 |
| abstract_inverted_index.concerns | 223 |
| abstract_inverted_index.duration | 167 |
| abstract_inverted_index.infected | 109 |
| abstract_inverted_index.lockdown | 34 |
| abstract_inverted_index.physical | 30 |
| abstract_inverted_index.reported | 103, 125 |
| abstract_inverted_index.reports. | 84 |
| abstract_inverted_index.symptoms | 4, 89, 115, 127, 207 |
| abstract_inverted_index.Infection | 130 |
| abstract_inverted_index.collected | 80, 91 |
| abstract_inverted_index.conducted | 19 |
| abstract_inverted_index.increased | 132 |
| abstract_inverted_index.infection | 11, 46, 75, 172, 184, 226 |
| abstract_inverted_index.infective | 199 |
| abstract_inverted_index.performed | 41 |
| abstract_inverted_index.recovery. | 14, 129, 213 |
| abstract_inverted_index.symptoms, | 190 |
| abstract_inverted_index.symptoms. | 76 |
| abstract_inverted_index.unrelated | 178 |
| abstract_inverted_index.warranted | 242 |
| abstract_inverted_index.SARS-CoV-2 | 65 |
| abstract_inverted_index.complained | 111 |
| abstract_inverted_index.complaints | 6, 134 |
| abstract_inverted_index.congestion | 193 |
| abstract_inverted_index.especially | 191 |
| abstract_inverted_index.healthcare | 26, 83 |
| abstract_inverted_index.identified | 51 |
| abstract_inverted_index.infection; | 105, 119 |
| abstract_inverted_index.infections | 153, 156 |
| abstract_inverted_index.knockdown. | 146 |
| abstract_inverted_index.persistent | 205 |
| abstract_inverted_index.Demographic | 77 |
| abstract_inverted_index.coronavirus | 69, 225, 235 |
| abstract_inverted_index.differences | 151 |
| abstract_inverted_index.examination | 175 |
| abstract_inverted_index.infections, | 236 |
| abstract_inverted_index.significant | 150 |
| abstract_inverted_index.conjunctival | 192 |
| abstract_inverted_index.examination. | 165 |
| abstract_inverted_index.examinations | 31, 160 |
| abstract_inverted_index.face-to-face | 93 |
| abstract_inverted_index.multi-center | 244 |
| abstract_inverted_index.populations. | 247 |
| abstract_inverted_index.comprehensive | 42 |
| abstract_inverted_index.examinations. | 44, 182 |
| abstract_inverted_index.interviewing. | 94 |
| abstract_inverted_index.noninfectious | 155 |
| abstract_inverted_index.participants, | 100 |
| abstract_inverted_index.self-reported | 54, 73 |
| abstract_inverted_index.significantly | 131 |
| abstract_inverted_index.nasopharyngeal | 61 |
| abstract_inverted_index.community-based | 246 |
| abstract_inverted_index.cross-sectional | 16 |
| abstract_inverted_index.Ophthalmologists | 40 |
| abstract_inverted_index.transcription-PCR | 56 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| corresponding_author_ids | https://openalex.org/A5100394234 |
| countries_distinct_count | 2 |
| institutions_distinct_count | 6 |
| corresponding_institution_ids | https://openalex.org/I191996457, https://openalex.org/I4210097509, https://openalex.org/I87780372 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7900000214576721 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.63499086 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |